These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7781875)

  • 1. Endometrial müllerian carcinosarcoma after cessation of tamoxifen therapy for breast cancer.
    Sasco AJ; Raffi F; Satgé D; Goburdhun J; Fallouh B; Leduc B
    Int J Gynaecol Obstet; 1995 Mar; 48(3):307-10. PubMed ID: 7781875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial mixed Müllerian tumor with heterologous elements following tamoxifen therapy for breast cancer: a case report and literature review.
    Kaleli S; Calay Z; Altinok T; Kösebay D
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):204-8. PubMed ID: 11858901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine malignant mixed müllerian tumor in a patient on long-term tamoxifen therapy for breast cancer.
    Clarke MR
    Gynecol Oncol; 1993 Dec; 51(3):411-5. PubMed ID: 8112655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial and other primary cancers after tamoxifen treatment of breast cancer -- results of retrospective cohort study.
    Ursic Vrscaj M; Kovacic J; Bebar S; Djurisic A; Fras PA; Robic V
    Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):105-10. PubMed ID: 11267730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patients.
    Ngô C; Brugier C; Plancher C; de la Rochefordière A; Alran S; Féron JG; Malhaire C; Scholl S; Sastre X; Rouzier R; Fourchotte V;
    Eur J Surg Oncol; 2014 Oct; 40(10):1237-44. PubMed ID: 25086993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
    Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
    J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
    Friedrich M; Villena-Heinsen C; Mink D; Bonkhoff H; Schmidt W
    Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):85-7. PubMed ID: 10192492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-irradiation carcinosarcoma of uterus--a case report.
    Sharma AB; Pukhrambam G; Laishram S
    Indian J Pathol Microbiol; 2006 Oct; 49(4):559-61. PubMed ID: 17183854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual breast cancers followed by endometrial cancer.
    Dimitrievich E; Sterzinger A
    S D J Med; 2002 Jun; 55(6):227-9. PubMed ID: 12082808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous uterine carcinosarcoma and contralateral breast cancer after tamoxifen therapy: a case report.
    Shen L; Hong L; Zhang G; Mai R
    Int J Clin Exp Pathol; 2014; 7(8):5295-301. PubMed ID: 25197413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature.
    Fotiou S; Hatjieleftheriou G; Kyrousis G; Kokka F; Apostolikas N
    Anticancer Res; 2000; 20(3B):2015-20. PubMed ID: 10928144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    Slomovitz BM; Sun CC; Ramirez PT; Bodurka DC; Diaz P; Lu KH
    Obstet Gynecol; 2004 Aug; 104(2):255-60. PubMed ID: 15291996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.
    Gupta M; Kiruthiga KG
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure.
    Fles R; Hoogendoorn WE; Platteel I; Scheerman CE; de Leeuw-Mantel G; Mourits MJ; Hollema H; van Leeuwen FE; van Boven HH; Nederlof PM
    Genes Chromosomes Cancer; 2010 Aug; 49(8):699-710. PubMed ID: 20544844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
    Magriples U; Naftolin F; Schwartz PE; Carcangiu ML
    J Clin Oncol; 1993 Mar; 11(3):485-90. PubMed ID: 8383191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.
    Fornander T; Hellström AC; Moberger B
    J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.
    Hachisuga T; Saito T; Kigawa J; Ohwada M; Yamazawa K; Yasue A; Iwasaka T; Sugiyama T; Kita T; Nagai N
    Gynecol Oncol; 2004 Oct; 95(1):139-44. PubMed ID: 15385123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
    Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F
    Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.
    Behtash N; Hashemi R; Karimi Zarchi M
    Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.